Servier’s decision to exit a Parkinson’s disease pact has triggered belt tightening at French biotech Oncodesign Precision Medicine. The loss of a shot at a milestone prompted OPM to lay off ...

Five months after cutting support for BDTX-4933, the biotech has licensed the RAF inhibitor to Servier for $70 million upfront and up to $710 million in milestones. In October, Black Diamond ...

SURESNES, France and CAMBRIDGE, Mass., March 19, 2025 (GLOBE NEWSWIRE) -- Servier, an independent global pharmaceutical group governed by a non-profit foundation, and Black Diamond Therapeutics ...

He recently revealed that he made himself available for the fourth film, The Matrix Resurrections, but was turned down to reprise his role as Morpheus — so being in the next one isn’t looking ...

Servier and Black Diamond Therapeutics (BDTX) announced a strategic worldwide licensing agreement for BDTX-4933, a potential best-in-class targeted therapy for solid tumors. Under this global ...

Servier will lead the development activities and the worldwide commercialization of BDTX-4933 across multiple indications. Currently, in Phase 1 development, BDTX-4933 is designed to target RAS ...

The partnership underscores Servier's commitment to developing targeted therapies that address unmet medical needs in oncology Servier will develop and commercialize BDTX-4933, a Phase 1 asset ...

He recently revealed that he made himself available for the fourth film, The Matrix Resurrections, but was turned down to reprise his role as Morpheus — so being in the next one isn’t looking ...

French pharma group Servier has formed a second partnership with Aitia focusing on the use of artificial intelligence and digital twins to help discover and develop new therapies for cancer.

Yahya Abdul-Mateen II played a younger version of Morpheus in the 2021 film – and, according to Fishburne, he was turned down when he said he was up for starring in the film. “I offered my ...

Builders can present AI agents to capital providers, accessing funding via Morpheus smart contracts at the event. Morpheus awarded $1M to 75 builder subnets in February, following $10M MOR rewards ...